LINC00662
gene geneOn this page
Summary
LINC00662 (long intergenic non-protein coding RNA 662, HGNC:27122) is a long non-coding RNA gene on chromosome 19q11.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27122 |
| Approved symbol | LINC00662 |
| Name | long intergenic non-protein coding RNA 662 |
| Location | 19q11 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000261824 |
| Ensembl biotype | lncRNA |
| Entrez | 148189 |
| RNAcentral | URS000075BAA8 — lncRNA, 2085 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 93 — 93 lncRNA
ENST00000561521, ENST00000586248, ENST00000586954, ENST00000588027, ENST00000588150, ENST00000590523, ENST00000590677, ENST00000591338, ENST00000591458, ENST00000653317, ENST00000653404, ENST00000653459, ENST00000653471, ENST00000654098, ENST00000654151, ENST00000654443, ENST00000654565, ENST00000654892, ENST00000655066, ENST00000655166, ENST00000655465, ENST00000655567, ENST00000656086, ENST00000656170, ENST00000656191, ENST00000656221, ENST00000656647, ENST00000656708, ENST00000656728, ENST00000657659, ENST00000657677, ENST00000657730, ENST00000658434, ENST00000658654, ENST00000658694, ENST00000658794, ENST00000659364, ENST00000659422, ENST00000659734, ENST00000659785, ENST00000659922, ENST00000659995, ENST00000660418, ENST00000660820, ENST00000661680, ENST00000662444, ENST00000662487, ENST00000663492, ENST00000663775, ENST00000664204, ENST00000664383, ENST00000664444, ENST00000664688, ENST00000664720, ENST00000664921, ENST00000665102, ENST00000665874, ENST00000665996, ENST00000666003, ENST00000666409, ENST00000666658, ENST00000666734, ENST00000666841, ENST00000667396, ENST00000667518, ENST00000667678, ENST00000668068, ENST00000668513, ENST00000668560, ENST00000668933, ENST00000669191, ENST00000670305, ENST00000670572, ENST00000670973, ENST00000671152, ENST00000671227, ENST00000671282, ENST00000687807, ENST00000690193, ENST00000690384, ENST00000749058, ENST00000749059, ENST00000749060, ENST00000749061, ENST00000749062, ENST00000749063, ENST00000749064, ENST00000749065, ENST00000749066, ENST00000749067, ENST00000749068, ENST00000749069, ENST00000749070
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000561521 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002605939 | 27732796 | 27732967 |
| ENSE00002894924 | 27746098 | 27746340 |
| ENSE00003987350 | 27730273 | 27732447 |
| ENSE00003987351 | 27793000 | 27793195 |
Expression profiles
Bgee: expression breadth ubiquitous, 212 present calls, max score 95.65.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 27.8853 / max 1250.5871, expressed in 1736 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180327 | 10.9580 | 1090 |
| 180328 | 7.7634 | 1381 |
| 180332 | 5.3134 | 1619 |
| 180326 | 1.4918 | 276 |
| 180331 | 1.3328 | 689 |
| 180324 | 0.5251 | 107 |
| 180330 | 0.2258 | 119 |
| 180325 | 0.1760 | 76 |
| 180329 | 0.0990 | 37 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 95.65 | gold quality |
| cortical plate | UBERON:0005343 | 92.08 | gold quality |
| left testis | UBERON:0004533 | 87.95 | gold quality |
| right testis | UBERON:0004534 | 87.75 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.63 | gold quality |
| calcaneal tendon | UBERON:0003701 | 87.10 | gold quality |
| testis | UBERON:0000473 | 87.06 | gold quality |
| sural nerve | UBERON:0015488 | 86.95 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.81 | gold quality |
| pancreatic ductal cell | CL:0002079 | 86.32 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 86.25 | gold quality |
| sperm | CL:0000019 | 85.56 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 84.92 | gold quality |
| right frontal lobe | UBERON:0002810 | 84.79 | gold quality |
| cerebellar cortex | UBERON:0002129 | 84.53 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 84.52 | gold quality |
| ventricular zone | UBERON:0003053 | 84.34 | gold quality |
| hypothalamus | UBERON:0001898 | 84.27 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 84.02 | gold quality |
| cerebellum | UBERON:0002037 | 83.76 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 83.73 | gold quality |
| tendon | UBERON:0000043 | 83.42 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 83.30 | gold quality |
| kidney epithelium | UBERON:0004819 | 82.69 | gold quality |
| amygdala | UBERON:0001876 | 82.48 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.45 | gold quality |
| muscle of leg | UBERON:0001383 | 82.44 | gold quality |
| nucleus accumbens | UBERON:0001882 | 82.37 | gold quality |
| adrenal tissue | UBERON:0018303 | 82.28 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 82.02 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.65 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 25)
- Data suggest that overexpression of Linc00662 enhances lung cancer cell metastasis and cancer stem cell characteristics; these characteristics seem to involve interaction of Linc00662 with LIN28 in lung cancer cells; lung cancer patients with higher Linc00662 expression levels exhibit lower overall survival rate than patients with lower Linc00662 expression levels. (LIN28 = RNA-binding protein LIN-28) (PMID:30256974)
- critical role for the LINC00662-miR-497-5p-YAP1 axis in gastric cancer cell growth (PMID:30297104)
- Long noncoding RNA LINC00662 functions as miRNA sponge to promote the prostate cancer tumorigenesis through targeting miR-34a. (PMID:31114993)
- the important role of the LINC00662/miR-340-5p/ROCK1 axis in regulating the malignant behavior of AML cells (PMID:31306637)
- Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/beta-catenin signaling. (PMID:31785055)
- Long noncoding RNA LINC00662-miR-15b-5p mediated GPR120 dysregulation contributes to osteoarthritis. (PMID:32037689)
- LINC00662 triggers malignant progression of chordoma by the activation of RNF144B via targeting miR-16-5p. (PMID:32096180)
- TRA2A-induced upregulation of LINC00662 regulates blood-brain barrier permeability by affecting ELK4 mRNA stability in Alzheimer’s microenvironment. (PMID:32372707)
- LINC00662 promotes glycolysis and cell survival by regulating miR- 375/HIF-1alpha axis in ovarian cancer. (PMID:32476381)
- Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis. (PMID:32558530)
- LINC00662 contributes to the progression and the radioresistance of cervical cancer by regulating miR-497-5p and CDC25A. (PMID:32869878)
- LINC00662 promotes cell proliferation, migration and invasion of melanoma by sponging miR-890 to upregulate ELK3. (PMID:32894549)
- Silencing linc00662 inhibits cell proliferation and colony formation of lung cancer cells via regulating the miR-145-5p-PAFAH1B2 axis. (PMID:33108738)
- [Long noncoding RNA Linc00662 promotes the tumorigenesis of prostate cancer cells]. (PMID:33377712)
- Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis. (PMID:33589572)
- LINC00662 modulates cervical cancer cell proliferation, invasion, and apoptosis via sponging miR-103a-3p and upregulating PDK4. (PMID:33819358)
- LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis. (PMID:34164962)
- A positive feedback loop of LINC00662 and STAT3 promotes malignant phenotype of glioma. (PMID:34246852)
- LINC00662 facilitates osteosarcoma progression via sponging miR-103a-3p and regulating SIK2 expression. (PMID:34559955)
- Long intergenic non-protein coding RNA 662 accelerates the progression of gastric cancer through up-regulating centrosomal protein 55 by sponging microRNA-195-5p. (PMID:35037833)
- LINC00662 Promotes Proliferation and Invasion and Inhibits Apoptosis of Glioma Cells Through miR-483-3p/SOX3 Axis. (PMID:35275355)
- METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer. (PMID:36202872)
- The role and mechanisms of long non-coding RNA LINC00662 in promoting the proliferation, migration, and angiogenesis of BGC-823 and HGC-27 cells and the subsequent effect on the progression of gastric cancer. (PMID:37087562)
- LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the beta-catenin signaling pathway. (PMID:38169586)
- LINC00662 Promotes Aggressive Traits by Modulating OCT4 Expression through miR-335-5p in Gallbladder Cancer Cells. (PMID:38928444)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.